Overview
Toolgen is positioning itself as a leader in the field of CRISPR-Cas9 technology by actively engaging in research and development, patent acquisition, safety evaluation measures, and advancements to improve the functionality of CRISPR-Cas9. The technology's versatility allows it to be applied across a wide range of fields, similar to the way existing drugs can generate multiple candidate substances. Additionally, we are exploring opportunities to expand our business by utilizing this platform technology.